Latest Nabi Stories

2008-09-10 12:00:51

Nabi Biopharmaceuticals has announced that the National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, has entered into collaboration with Nabi to advance the company's PentaStaph vaccine candidate for the prevention and treatment of Staphylococcus aureus infections in the community and hospital settings. The focus of the collaboration is to conduct preclinical toxicology evaluations of two new S aureus antigens as components of the multivalent...

2008-07-24 12:01:22

Nabi Biopharmaceuticals has announced positive interim results from its Phase II NicVAX schedule optimization immunogenicity study to assess the antibody response and safety of a 400 microgram, six dose immunization schedule. Interim results from the study indicate that significantly higher anti-nicotine antibody levels can be generated three months earlier and in a much higher percentage of subjects than observed in previous NicVAX studies. Nabi's new immunization schedule, which...

Word of the Day
  • Color; hue; complexion.
This word is Middle English in origin.